# Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19

> **NCT04604678** · PHASE2 · WITHDRAWN · sponsor: **AgelessRx**

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Metformin
- **DRUG:** Naltrexone

## Key facts

- **NCT ID:** NCT04604678
- **Lead sponsor:** AgelessRx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-02
- **Primary completion:** 2021-08
- **Final completion:** 2021-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to recruit participants due to restrictive inclusion/exclusion criteria. Will update protocol with IRB \& begin anew after approval.
- **Last updated:** 2022-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04604678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04604678, "Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT04604678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*